Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04725994
Title Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Idience Co., Ltd.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.